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The Lancet Global Health 
Commission on High 
Quality Health 
Systems—where’s the 
complexity? 
Authors’ reply
Stephanie Topp points to the 
limitations of quality measurement in 
The Lancet Global Health Commission 
on High Quality Health Systems 
(HQSS Commission; May, 2017)1 that 
might not fit the real-world contexts 
of low-income and middle-income 
countries (LMICs). She also takes issue 
with a narrow set of generic indicators 
and targets for quality that might be 
meaningless or even provide “perverse 
incentives to game the system”. We 
agree these are important concerns 
and aim to tackle them in the work of 
the Commission.
The HQSS Commission’s goal is 
to move quality from a specialised, 
niche enterprise to a core pursuit of 
health systems, hence the need for 
a single, shared definition among 
policymakers, users, and providers. 
Improvements to accountability of 
health systems to users requires robust 
and timely information about what is 
going right or wrong when people 
access care. This information is not 
systematically available in most LMICs 
today, nor is there agreement about 
which information is needed across 
health conditions and the different 
parts of a health system. But we agree 
that measurement can be onerous 
and indicators can be unconnected to 
meaningful outcomes. For example, 
we are finding that the hundreds of 
indicators of equipment and supplies 
routinely collected in facility surveys 
do not shed much light on the content 
of the care people receive—a much 
more important construct.
We agree that all measures should 
have a clear purpose and audience. 
In its work on measurement, the 
Commission will emphasise the need 
for actionable measures at different 
levels that permit advocacy for high 
quality care, promote accountability 
of the health system, and guide quality 
improvement actions. We will place a 
premium on measuring what matters 
most to users and on summative 
measures that capture the functioning 
of the health system as a whole. 
We share Topp’s skepticism of using 
simple targets in place of tackling root 
causes; indeed, we intend to focus 
on structural approaches to quality 
improvement, such as governance, 
management, care delivery models, 
professional  education,  and 
regulation, among others that have 
influence across the health-care 
delivery chain. These approaches 
will necessarily take different shape 
in different LMICs to respond to the 
diverse organisational structures and 
nature of quality challenges. 
To contextualise the Commission’s 
work, several national Commissions, 
including in Ethiopia and South 
Africa, will test and refine the global 
guidance by application to their 
particular settings. Nearly half the 
Commissioners are policymakers, most 
of whom are from LMICs; they too will 
reality-test our recommendations 
as the work progresses. Ultimately, 
the Commission will endorse those 
measures that are useful in holding 
health systems to account for 
improving health and for providing 
value to their users. 
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